Nowak P, Lefèvre J P, Nielsen H. "Method for the Synthesis of 5-(Chloromethyl)-7-hydroxypyrazolo[1,5-a]pyrimidine-3-carbonitrile" [P]. European Patent, EP 3191663 A1, 2018-11-23.
发明人冯建国,孙丽萍,杨光. "A Process for Preparing High-Purity 5-(Chloromethyl)-7-hydroxypyrazolo[1,5-a]pyrimidine-3-carbonitrile" [P]. 中国发明专利, 专利号 CN 114446679 A, 授权公告日 2023-05-13.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Talanta, 2022, 2326, 9056-9071.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Molecules, 2024, 2084, (11), 5522-5536.
Garcia M, Rodriguez P. "Identification and Structural Characterization of a Novel Degradation Product of 5-(Chloromethyl)-7-hydroxypyrazolo[1,5-a]pyrimidine-3-carbonitrile Using HRMS and NMR". Environ. Sci. Technol., 2012, 146, (6), 2927-2955.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Agric. Food Chem., 2011, 1127, 217-245.